| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 25 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 25 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 25 |
| 3 | BUSULFAN | 15 |
| 4 | ETOPOSIDE | 8 |
| 5 | FLUDARABINE PHOSPHATE | 8 |
| 6 | NIROGACESTAT | 7 |
| 7 | CARBOPLATIN | 5 |
| 8 | THIOTEPA | 4 |
| 9 | DOXORUBICIN | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NIROGACESTAT | 7 | 0.0076 |
| 1 | BUSULFAN | 15 | 0.0009 |
| 2 | ESTRADIOL, FOLLICULINUM, OOPHORINUM (SUIS) | 1 | 0.0004 |
| 3 | THIOTEPA | 4 | 0.0004 |
| 4 | LOMUSTINE | 1 | 0.0004 |
| 5 | ELAGOLIX | 1 | 0.0003 |
| 6 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 1 | 0.0002 |
| 7 | FLUDARABINE PHOSPHATE | 8 | 0.0002 |
| 8 | IFOSFAMIDE FOR INJECTION | 3 | 0.0001 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 25 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 30 |
| 1 | Topoisomerase Inhibitor [EPC] | 8 |
| 2 | Gamma Secretase Inhibitor [EPC] | 7 |
| 3 | Platinum-based Drug [EPC] | 6 |
| 4 | Corticosteroid [EPC] | 4 |
| 5 | Estrogen [EPC] | 2 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 2 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 2 |
| 8 | Purine Antimetabolite [EPC] | 2 |
| 9 | Aminosalicylate [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Gamma Secretase Inhibitor [EPC] | 7 | 0.0076 |
| 1 | Alkylating Drug [EPC] | 30 | 0.0001 |
| 2 | Topoisomerase Inhibitor [EPC] | 8 | 0.0001 |
| 3 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 4 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Platinum-based Drug [EPC] | 6 | 0.0000 |
| 6 | Purine Antimetabolite [EPC] | 2 | 0.0000 |
| 7 | Tetracycline-class Drug [EPC] | 1 | 0.0000 |
| 8 | Estrogen [EPC] | 2 | 0.0000 |
| 9 | Aminosalicylate [EPC] | 1 | 0.0000 |